Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
7.36 USD | 0.00% | +3.37% | -38.72% |
Summary
- The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.
Strengths
- Growth is a substantial asset for the company, as anticipated by dedicated analysts. Within the next three years, growth is estimated to reach 66% by 2027.
- Thanks to a sound financial situation, the firm has significant leeway for investment.
- With regards to fundamentals, the enterprise value to sales ratio is at 0.83 for the current period. Therefore, the company is undervalued.
- For the last twelve months, analysts have been gradually revising upwards their EPS forecast for the upcoming fiscal year.
- Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
- The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
Weaknesses
- The company's profitability before interest, taxes, depreciation and amortization characterizes fragile margins.
- Low profitability weakens the company.
- For the last few months, analysts have been revising downwards their earnings forecast.
- The average price target of analysts who are interested in the stock has been significantly revised downwards over the last four months.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Healthcare Facilities & Services
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-38.72% | 577M | C- | ||
-28.75% | 70.3B | B- | ||
+2.04% | 27.46B | C+ | ||
-6.19% | 17.8B | B | ||
+2.32% | 17.46B | A- | ||
+2.10% | 15.46B | A- | ||
+7.06% | 13.49B | B- | ||
+10.80% | 13.06B | A- | ||
+71.31% | 12.96B | C- | ||
+75.96% | 12.56B | C+ |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- ACCD Stock
- Ratings Accolade, Inc.